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Background: Infective endocarditis is a rare diagnosis in pediatrics. Group A beta-hemolytic Streptococcus pyogenes
is known to cause a range of type and severity of infections in childhood. However, S. pyogenes is a rarely described
cause of endocarditis in children. This paper presents two cases of S. pyogenes endocarditis and the largest and
most up-to-date review of cases previously reported in the literature.
Case presentation: Here we describe two pediatric cases of S. pyogenes endocarditis with associated toxic shock.
Case 1 was a previously well Caucasian 6-year-old female who presented with sepsis. Case 2 was an 8-month-old
South Asian female who presented with sepsis and pneumonia. We present a review of the literature since the
beginning of the antibiotic era of this unusual cause of bacterial endocarditis in children.
Conclusion: In addition to the two cases presented here, a total of 13 children have been reported since 1940 with
endocarditis caused by S. pyogenes for which clinical details are available. Although few cases exist, literature review
reveals a high mortality rate (27%) and the majority of patients who recovered had residual morbidities. We
emphasize the importance of considering a diagnosis of endocarditis in cases of S. pyogenes sepsis or toxic shock in
order to ensure early diagnosis and timely treatment, which are necessary for good outcomes. This information is
relevant to both general and subspecialty pediatricians, especially emergency room and infectious disease
physicians.
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Infective endocarditis (IE) is a rare diagnosis in children.
Group A beta-hemolytic Streptococcus pyogenes can cause
a range of type and severity of infections in childhood in-
cluding invasive, toxin-mediated, and immune-mediated
disease. However, S. pyogenes is a rarely described cause of
IE in children. The estimated proportion of IE caused by
S. pyogenes in children under age 21 is less than 3% [1]. In
addition to the two cases presented here, a total of 13 chil-
dren have been reported since 1940 with endocarditis
caused by S. pyogenes for which clinical details are avail-
able. Here we describe two cases of IE caused by S. pyo-
genes in children with associated toxin-mediated disease,* Correspondence: shaun.morris@sickkids.ca
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unless otherwise stated.and present a review of the literature since the beginning
of the antibiotic era.
Case presentation
Case 1
A 6-year-old previously healthy unvaccinated Caucasian
female was seen at a rural emergency department (ED)
with a 3-week history of fevers and a 3-day history of
lethargy, poor oral intake, and erythematous rash. Fol-
lowing discharge from the ED, she re-presented two days
later to the same ED with fever and signs consistent with
sepsis. She was transferred to the intensive care unit
(ICU) of our tertiary care center after fluid rehydration
and one dose of ceftriaxone. At least 3 of her 6 siblings
had a recent history of pharyngitis, although only one was
seen by a physician, diagnosed clinically as strep throat,
and treated. On examination she had a systolic murmur,
painful purple nodules of the fingers and toes, and ery-
thema of the palms and soles. She was hypotensive and re-
quired dopamine and epinephrine infusions to maintainral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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with 73% neutrophils. Initial electrocardiogram (ECG) was
normal. Antimicrobial therapy initiated on admission was
vancomycin and meropenem. Transthoracic echocardio-
gram (echo) was done due to clinical stigmata suspicious
for IE, which demonstrated a mobile mass on the poster-
ior mitral leaflet (0.7 cm × 0.5 cm) and a small atrial septal
defect (ASD)/patent foramen ovale (PFO). Head com-
puted tomography (CT) revealed multiple bilateral asym-
metric hypoattenuating foci, presumed to be septic emboli
or watershed infarcts. Once the diagnosis of IE was made,
gentamicin was added. Three hours after admission to the
ICU, cardiac monitor abnormalities prompted a repeat
ECG, which showed accelerated junctional rhythm and
atrioventricular (AV) dissociation. The decision was made
not to operate, as her echo showed good function and no
aortic root abscess. On day 2 of admission, blood cultures
drawn at the community hospital came back positive for
S. pyogenes. Penicillin (400,000 units/kg/day) and clinda-
mycin were started; gentamicin was discontinued. By day
3 of admission, she had clinically improved and vanco-
mycin and meropenem were stopped. Blood cultures
drawn on admission to our institution were sterile. She
improved rapidly on penicillin and by day 5 of admission,
the suspected toxin-mediated process had resolved, and
clindamycin was discontinued. Liver and renal function
remained normal. She was discharged home 8 days after
presentation and completed 6 weeks of intravenous peni-
cillin (400,000 units/kg/day). Complete resolution of the
vegetation was seen on 3-month follow-up echo.
Case 2
A previously well 8-month-old South Asian female pre-
sented to a community hospital with a clinical picture
suggestive of sepsis. She had a 1-week history of fevers
and viral respiratory prodrome and a 2-day history of
lethargy and poor oral intake. On initial presentation,
she had increased work of breathing and chest x-ray
demonstrated a right pleural effusion. She was initially
treated with vancomycin, cefotaxime, and oseltamivir.
On day 2 of hospitalization, she was intubated due to
worsening lethargy, poor perfusion, and acidosis. She
was then transferred to the ICU at our tertiary care facil-
ity where hemodynamic support was provided and a
chest tube was placed. Blood cultures drawn from the
community hospital grew S. pyogenes and penicillin
(300,000 units/kg/day) and clindamycin were started.
Repeat blood cultures at our institution were also posi-
tive for S. pyogenes. Due to hemodynamic instability, a
transthoracic echocardiogram was performed to assess
cardiac function. The study was limited by clinical in-
stability but did not show evidence of endocarditis.
In addition to hypotension, she developed multi-organ
dysfunction including acute renal failure, elevated liverenzymes, and thrombocytopenia. On day 6 of illness, she
had left hand twitching and bilateral abnormal eye
movements. Head CT showed extensive bilateral asym-
metric foci of white matter diffusion restriction consist-
ent with watershed infarcts and right parietal lobe
findings suggestive of hemorrhagic septic emboli. Repeat
transthoracic echocardiogram showed a tricuspid valve
vegetation and a PFO. High dose penicillin was contin-
ued and blood cultures became negative after one week of
antibiotic therapy. She was transferred to the ward on day
18 of illness and discharged home after 34 days total. Peni-
cillin (300,000 units/kg/day) was continued to complete
6 weeks, and she had complete resolution of symptoms on
follow-up.
Discussion
Infective endocarditis is unusual in children and carries
significant morbidity and mortality. S. pyogenes is a rare
cause of this condition. This organism is a virulent cause
of endocarditis, as the infection has the potential to pro-
gress despite appropriate therapy, which can ultimately
lead to death [2].
Prior to the antiobiotic era, infective endocarditis was
nearly always fatal, regardless of the causal pathogen [3].
Incidence of endocarditis caused by S. pyogenes has de-
clined significantly since the introduction of antiobiotics,
largely due to antibiotic treatment of local pyogenic in-
fections preventing bacteremia and seeding of the endo-
cardium [4].
While underlying congenital heart disease is consid-
ered a major risk factor for endocarditis [3], the cases
we present and the majority of those with S. pyogenes
endocarditis reported in the literature occurred in chil-
dren with structurally normal hearts. This is consistent
with the epidemiology of other causes of endocarditis in
children, which has shifted in recent years to affect a
higher proportion of children without underlying struc-
tural heart disease [1].
Bacteremia caused by S. pyogenes comes from a primary
source, which may be cellulitis, pharyngitis, endometritis,
pneumonia, or other localized pyogenic infection. In chil-
dren, the primary source is most commonly pharyngitis or
skin lesions [5]. Superinfection of varicella skin lesions
with S. pyogenes is the most common focus of infection
leading to endocarditis by this organism [6,7]. However,
endocarditis as a complication of varicella is very unusual
[8]. In Case 1, the portal of entry was likely pharyngitis.
Although less clear in Case 2, the initial infection may
have been pneumonia.
S. pyogenes can produce multiple exotoxins, which have
potential to cause end organ damage or release cytokines
that can cause tissue injury [5]. The syndrome of toxic
shock caused by S. pyogenes endocarditis is uncommon, es-
pecially in children. Both cases we describe are consistent
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• Painful swollen joints
2 [3] 1975 6 m, M None Meningitis Aortic • Microscopic hematuria None No Recovered with cardiomegaly
and decreased cardiac function
• LVHb
• Aortic insufficiency and CHFc
• Left sinus of Valsalva aneurysum
3 [13] 1977 14y, M VSDd closed surgically at
age 6, aortic stenosis
Tonsillitis Aortic • Myocardial abscesses Not reported No Death
• Rupture of sinus of Valsalva
into left ventricle
4 [4] 1980 16y, M None Febrile sore throat Aortic • Respiratory distress requiring
intubation and ventilation
Peripheral, Renal No Recovered
• Renal failure (resolved)




6 [6] 1988 4 m, F None Varicella Aortic • Para-aortic abscess None No Death
• CHFc and pulmonary edema
7 [14] 1988 4y, F None None Aortic • Polyarthritis None Yes Recovered with small VSDd
• Aortic regurgitation
• Sinus of Valsalva aneurysm







9 [5,15] 1998 14y, M None None Mitral • Right cerebral infarction Brain No Recovered with
left-sided weakness





















Table 1 Cases of S. pyogenes endocarditis from 1940 to present for which clinical features are available (Continued)
• Mitral regurgitation with anterior leaflet tear
• Aortic root abscess
• Toe autoamputation
11 [16] 2000 4y, M None None Mitral • Mitral regurgitation Left foot Yes Recovered
• Necrosis of 2 toes
requiring amputation
12 [16] 2000 2y, M None Varicella Aortic • Aortic root abscess Brain, Peripheral Yes Recovered with
left hemiplegia
• Aortic valve perforation
• Focal seizures
13 [8] 2000 3y, M None Varicella Aortic • Joint pain Peripheral Yes Recovered
• Bilateral pulmonary infiltrates
• Elevated LFTse
• Aortic insufficiency
• Left ventricular dilatation leading to CHFc
aIncludes all cases from which clinical features, demographics, and outcome can be extracted. There exists an additional group of cases of possible S. pyogenes endocarditis in children for which sufficient clinical data
is not available [1,17-21]. As well, a few cases were excluded due to ambiguity [21,22].
bLVH = left ventricular hypertrophy.
cCHF = congestive heart failure.
dVSD = ventricular septal defect.
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definition of toxic shock [9], as she had hypotension as well
as multi-organ involvement including renal impairment,
liver dysfunction, coagulopathy, and respiratory distress.
Case 1 had features of toxic shock including hypotension
and a generalized rash; however, the clinical picture does not
meet formal criteria [9]. There are few cases of toxic shock
associated with S. pyogenes endocarditis in the literature. The
case reported by Liu et al. required intubation, vasopressors,
and fluid resuscitation, although toxic shock is not specific-
ally discussed [7]. As well, Winterbotham et al. describe a
case with hypotension and respiratory failure; however, the
details are unclear [5]. In general, few cases described previ-
ously were as clinically unstable as those presented here.
Since these two cases presented to our tertiary care facil-
ity within two weeks of each other, we analyzed the strains
of S. pyogenes to see if the two cases may have been caused
by identical strains. The technique used was emm typing
by PCR done by the National Microbiology Laboratory
[10,11]. The strains were shown to be different.
Review of the literature
We conducted an electronic literature search using
PubMed and restricted to English language but did not
place restrictions on search dates. We further examined
reference lists in retrieved articles for additional citations
not found by the electronic search.
In addition to the two cases presented above, a total of
13 children have been reported since 1940 with endocar-
ditis caused by S. pyogenes for which clinical details are
available. In this review, cases from the antibiotic era
were included (Table 1). As such, this resulted in the ex-
clusion of several cases that did not have clinical infor-
mation available, or were presented with inconsistencies
or ambiguous nomenclature (Table 1).
Out of 15 cases of S. pyogenes endocarditis with clinical
information available (including those presented above), 10
were male (67%) and 5 were female (33%). Ages range from
4 months to 16 years, with a median age of 3 years. Only 2
patients had known pre-existing heart defects. Varicella was
a preceding infection in 4 cases (27%), and 6 patients (40%)
had no known preceding infection. The most common
valves involved were mitral and aortic, with each account-
ing for approximately 50%. Case 2 is the only reported case
in this population with IE affecting the tricuspid valve. Em-
bolic phenomenon occurred in 11 patients (79%), with one
not documented. Five patients had cardiac surgery (33%).
The mortality rate was 27% and the majority of patients
who recovered had residual morbidities.
Conclusions
In summary, we present a rare combination of endocar-
ditis caused by S. pyogenes in two children with previ-
ously normal hearts admitted to the same hospital in atwo-week time period, both with signs of toxic shock.
Our cases show that in cases of S. pyogenes sepsis or
toxic shock, consideration should be given to a concurrent
diagnosis of endocarditis, even if the heart is structurally
normal. When treated with appropriate antimicrobial
therapy and supportive care in a timely manner, even se-
vere presentations of S. pyogenes endocarditis and toxic
shock can have excellent outcomes.
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